L Kernisant Md - Brooklyn, New York 11217

L Kernisant Md is categorized under Doctors in Brooklyn, NY .

Business Name: L Kernisant Md
Contact Person: L Kernisant
Address: 345 Skimmerhorn St, Brooklyn, New York 11217
Phone Number: (312) 254-5900
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 1984
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Boro Medical Of New York Inc - Brooklyn, NY 11217
Richard J Calame Md - Brooklyn, NY 11217
Brooklyn Womens Healthcare - Brooklyn, NY 11217
Endocrine Technology LLC - Brooklyn, NY 11217
Holistic Primary Care - Brooklyn, NY 11217
Kernisant Lesly MD - Brooklyn, NY 11217
Stewart Jonathan MD - Brooklyn, NY 11217
Manter Kristen MD - Brooklyn, NY 11217
Daniel S Mundy MD - Brooklyn, NY 11217
Smerd Rachel MD - Brooklyn, NY 11217
Belkin Regina MD - Brooklyn, NY 11217
Ednalino Edgar Y MD - Brooklyn, NY 11217
Alcantara Teodorico M MD - Brooklyn, NY 11217
Alexis Georgette A MD - Brooklyn, NY 11217
Gordon Philippa Md - Brooklyn, NY 11217
Manzo Thomas J MD - Brooklyn, NY 11217
New York Mthdst Hosp-Radiology - Brooklyn, NY 11217
Douglas H Bailyn Md P C - Brooklyn, NY 11217
Philippa R Gordon MD - Brooklyn, NY 11217
Jean-Baptiste Gary E MD - Brooklyn, NY 11217

The company L Kernisant Md provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for L Kernisant Md, and the business now earns $100.000 to $499.999 per annum.

L Kernisant Md was launched in 1984 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact L Kernisant Md, please call L Kernisant with the phone number (312) 254-5900 or visit its single location at 345 Skimmerhorn St in Brooklyn, New York 11217.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.